December 2, 2022
Loading...
You are here:  Home  >  'Westlake Village BioPartners'
Latest

Company backed by Westlake Village BioPartners closes $300M capital raise

By   /  Tuesday, September 13th, 2022  /  Health Care & Life Science, Latest news, Regions, Startups, Subscriber content, Ventura County  /  Comments Off on Company backed by Westlake Village BioPartners closes $300M capital raise

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Street Smarts: Another honor for Westlake Village BioPartners co-founder

By   /  Friday, January 28th, 2022  /  Columns, Health Care & Life Science, Latest news, Nonprofits  /  Comments Off on Street Smarts: Another honor for Westlake Village BioPartners co-founder

The Healthcare Businesswomen’s Association has named Beth Seidenberg of Westlake Village BioPartners as its 2022 Woman of the Year. She will be feted live and virtually at the HBA’s annual conference in New York City on May 10. Seidenberg “has medicine in her blood,” a statement from the association says, noting that as a researcher Read More →

Latest

Capsida’s new CEO hopes success is in the genes

By   /  Friday, January 7th, 2022  /  East Ventura County, Health Care & Life Science, Latest news, Subscriber content, Technology, Top Stories, Top Story, Tri-County Economy  /  Comments Off on Capsida’s new CEO hopes success is in the genes

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Capsida names new CEO

By   /  Tuesday, December 7th, 2021  /  East Ventura County, Health Care & Life Science, Latest news, Technology, Top Stories, Tri-County Economy  /  Comments Off on Capsida names new CEO

Capsida Biotherapeutics, a venture-backed Thousand Oaks company developing gene therapy treatments, announced the hiring of a new CEO on Dec. 7. In April, Capsida emerged from “stealth mode” and closed a $140 million series A funding round, one of the largest venture capital raises of the year in the region’s life sciences sector. Capsida is Read More →

Latest

Westlake Village BioPartners makes big bet on gene therapy with Capsida

By   /  Friday, May 7th, 2021  /  East Ventura County, Health Care & Life Science, Latest news, Subscriber content, Technology, Top Stories, Tri-County Economy  /  Comments Off on Westlake Village BioPartners makes big bet on gene therapy with Capsida

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Thousand Oaks biotech firm closes $140M funding round

By   /  Thursday, April 29th, 2021  /  East Ventura County, Health Care & Life Science, Latest news, Startups, Technology, Tri-County Economy  /  Comments Off on Thousand Oaks biotech firm closes $140M funding round

Capsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →

Latest

‘Golden age of biotechnology’ comes to Conejo Valley

By   /  Friday, December 18th, 2020  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, Startups, Subscriber content, Technology, Top Stories, Tri-County Economy  /  Comments Off on ‘Golden age of biotechnology’ comes to Conejo Valley

Westlake Village BioPartners has launched two new funds worth a total of $500 million, bringing the total raised by the firm to more than $820 million since it was founded in 2018.